Table 2.
Biochemical findings.
Group | Median (25–75) | Multiple comparison results | |||
---|---|---|---|---|---|
Sepsis | Sepsis + carnosine | Control | |||
AST1 serum (U/l) baseline | Sepsis | 35.12±6.87 (1204–8913) | ns | ns | ns |
Sepsis + carnosine | 34.62±2.5 (50–5357) | ns | ns | ns | |
Control | 37.5±5.63 (183–336) | ns | ns | ns | |
H=0.995 DF=2 (P=0.608) | |||||
AST2 (U/l) | Sepsis | 383.87±17.5 (420–3543) | * | ** | |
Sepsis + carnosine | 119.5±11.3 (309–1575) | * | * | ||
Control | 50.37±9.55 (50–118) | ** | * | ||
H=14.256 DF=2 | |||||
ALT1 (U/l) baseline | Sepsis | 20.37±6.9 (3.20–7.66) | ns | ns | ns |
Sepsis + carnosine | 20.62±6.25 (1.89–3.76) | ns | ns | ns | |
Control | 21.5±4.1 (1.02–3.85) | ns | ns | ns | |
H=1.540 D=2 (P=0.463) | |||||
ALT2 (U/l) | Sepsis | 168.5±52.05 (10.8–26.7) | ** | ** | |
Sepsis + carnosine | 17.92±3.12 (6.98–8.34) | ** | |||
Control | 6.78±1.92 (5.2–11.9) | ** | |||
H=12.128 DF=2 | |||||
MDAT nmol/g.pr | Sepsis | 20.23±1.94 (43.8–75.6) | * | ** | |
Sepsis + carnosine | 12.28±0.75 (28.6–42.2) | * | |||
Control | 11.45±1.64 (10.2–11.9) | ** | |||
H=11.752 DF=2 | |||||
MDAS pg/ml | Sepsis | 7.78±1.42 (43.8–75.6) | * | ** | |
Sepsis + carnosine | 3.8±0.74 (28.6–42.2) | * | |||
Control | 2.41±0.66 (10.2–11.9) | ** | |||
H=17.956 DF=2 |
ns – p>0.05;
p<0.05;
p<0.001;
H – Kruskal-Wallis.